believe: β-thalassemia treatment with luspatercept reduces transfusion burden
Published 5 years ago • 2.4K plays • Length 7:08
Download video MP4
Download video MP3
Similar videos
-
5:33
luspatercept reduces transfusion burden in β-thalassemia
-
3:01
long-term results of believe: luspatercept in adults with transfusion-dependent beta-thalassemia
-
8:38
treating transfusion dependent and independent beta-thalassemia, and believe/beyond trial updates
-
2:02
beyond trial update: luspatercept in non-transfusion-dependent β-thalassemia
-
2:28
results of the believe study: luspatercept for the treatment of beta-thalassemia
-
14:53
beta-thalassemia (part 2) - beta-thalassemia minor
-
3:40
no sound reblozyl® (luspatercept-aamt) for anaemia
-
8:15
current approaches for beta-thalassemia
-
2:35
long-term results of the believe study: luspatercept in patients with beta-thalassemia
-
1:39
luspatercept in patients with hbe/β‑thalassemia: a subgroup analysis from the believe study
-
1:26
durable symptom improvement in ntd thalassemia treated with luspatercept in the beyond trial
-
2:09
past, present, and future management strategies for non-transfusion dependent β-thalassemia
-
3:26
phase iia study of vamifeport in patients with non-transfusion-dependent beta-thalassemia
-
1:00
luspatercept and mitapivat for the treatment of patients with beta-thalassemia
-
5:48
thalassemia: alpha & beta-thalassemias, genetics, pathophysiology, diagnosis & treatment, animation
-
2:30
cure2children: delivering transplant therapy for scd and thalassemia in developing countries
-
2:23
the current landscape of thalassemia treatment
-
1:47
benefits of beti-cel gene therapy for transfusion-dependent β-thalassemia
-
5:49
beti-cel gene therapy for transfusion-dependent β-thalassemia: 7-year follow up data
-
7:17
beta-thalassemia - causes, symptoms, diagnosis, treatment, pathology
-
1:48
toxicity of beti-cel in transfusion-dependent β-thalassemia
-
1:19
pb-04 in beta thalassemia intermedia and scd
Clip.africa.com - Privacy-policy